共用题干Clinical Trials1. Many clinical trials are done to see if a new drug or device is safe and effective for people to use.Sometimes clinical trials are used to study different ways to use the standard treatments so they will be more effective,easier to use,and/or decrease side effects.Sometimes,studies are done to learn how to best use the treatment in a different population,such as children,in whom the treatment was not previously tested.2. It is important to test drugs and medical products in the people they are meant to help.It is also important to conduct research in a variety of people because different people may respond differently to treatments.Some people participate in clinical trials because they have exhausted standard treatment options .Other people participate in trials because they want to contribute to the ad-vancement of medical knowledge.3. The FDA（食品及药物管理局）works to protect participants in clinical trials and to ensure that people have reliable information as they decide whether to join a clinical trial.Although efforts are made to control the risks to clinical trial participants,some risks may be unavoidable because of the uncertainty inherent（内在的）in medical research studies involving new medical treatments.4. People should learn as much as possible about the clinical trials that interest them.They should also feel comfortable discussing their questions and concerns with members of the health care team. Prospective（预期的）participants should understand what happens during the trial ,the type of health care they will receive,and any costs to them.Anyone considering a clinical trial should also know that there are benefits and risks associated with participating. New drugs or devices must be tested before being used______.A: candidates for clinical trialsB: during the trialC: medical knowledgeD: in humansE: before participationF: for some patients
共用题干
Clinical Trials
1. Many clinical trials are done to see if a new drug or device is safe and effective for people to use.Sometimes clinical trials are used to study different ways to use the standard treatments so they will be more effective,easier to use,and/or decrease side effects.Sometimes,studies are done to learn how to best use the treatment in a different population,such as children,in whom the treatment was not previously tested.
2. It is important to test drugs and medical products in the people they are meant to help.It is also important to conduct research in a variety of people because different people may respond differently to treatments.Some people participate in clinical trials because they have exhausted standard treatment options .Other people participate in trials because they want to contribute to the ad-vancement of medical knowledge.
3. The FDA（食品及药物管理局）works to protect participants in clinical trials and to ensure that people have reliable information as they decide whether to join a clinical trial.Although efforts are made to control the risks to clinical trial participants,some risks may be unavoidable because of the uncertainty inherent（内在的）in medical research studies involving new medical treatments.
4. People should learn as much as possible about the clinical trials that interest them.They should also feel comfortable discussing their questions and concerns with members of the health care team. Prospective（预期的）participants should understand what happens during the trial ,the type of health care they will receive,and any costs to them.Anyone considering a clinical trial should also know that there are benefits and risks associated with participating.
Clinical Trials
1. Many clinical trials are done to see if a new drug or device is safe and effective for people to use.Sometimes clinical trials are used to study different ways to use the standard treatments so they will be more effective,easier to use,and/or decrease side effects.Sometimes,studies are done to learn how to best use the treatment in a different population,such as children,in whom the treatment was not previously tested.
2. It is important to test drugs and medical products in the people they are meant to help.It is also important to conduct research in a variety of people because different people may respond differently to treatments.Some people participate in clinical trials because they have exhausted standard treatment options .Other people participate in trials because they want to contribute to the ad-vancement of medical knowledge.
3. The FDA（食品及药物管理局）works to protect participants in clinical trials and to ensure that people have reliable information as they decide whether to join a clinical trial.Although efforts are made to control the risks to clinical trial participants,some risks may be unavoidable because of the uncertainty inherent（内在的）in medical research studies involving new medical treatments.
4. People should learn as much as possible about the clinical trials that interest them.They should also feel comfortable discussing their questions and concerns with members of the health care team. Prospective（预期的）participants should understand what happens during the trial ,the type of health care they will receive,and any costs to them.Anyone considering a clinical trial should also know that there are benefits and risks associated with participating.
New drugs or devices must be tested before being used______.
A: candidates for clinical trials
B: during the trial
C: medical knowledge
D: in humans
E: before participation
F: for some patients
A: candidates for clinical trials
B: during the trial
C: medical knowledge
D: in humans
E: before participation
F: for some patients
参考解析
解析：第一段主要讲为什么要进行临床试验，其中谈到要研究如何安全有效地使用新药物或新仪器，如何使用方便并减少副作用，或用于不同人群等。
第二段主要讲什么人为什么参加临床试验，比方说，要观察不同人群的不同疗效，有的人已没有别的方法治疗，也有的人要为医疗事业作贡献等。
第三段主要讲参加临床试验的安全性问题。尽管FDA等会做出努力，但是新治疗方法的不确定性是不可避免的。
第四段主要讲人们参加临床试验前可以与有关医务人员充分讨论问题，了解试验的详情以及试验的利弊等。
短文第一句就说到，新药物或新仪器用于人体是否安全有效需要进行临床试验。
第二段第三句说到，有些人对于常规的治疗方法已无可选择，所以参加临床试验，当然就是他们的唯一希望了。
第三段第一句说到，FDA要保证，在人们决定是否参加临床试验的时候要获得可靠信，息。
整个第四段说到，准备参加临床试验的人们要尽可能多地了解有关临床试验的情况。
第二段主要讲什么人为什么参加临床试验，比方说，要观察不同人群的不同疗效，有的人已没有别的方法治疗，也有的人要为医疗事业作贡献等。
第三段主要讲参加临床试验的安全性问题。尽管FDA等会做出努力，但是新治疗方法的不确定性是不可避免的。
第四段主要讲人们参加临床试验前可以与有关医务人员充分讨论问题，了解试验的详情以及试验的利弊等。
短文第一句就说到，新药物或新仪器用于人体是否安全有效需要进行临床试验。
第二段第三句说到，有些人对于常规的治疗方法已无可选择，所以参加临床试验，当然就是他们的唯一希望了。
第三段第一句说到，FDA要保证，在人们决定是否参加临床试验的时候要获得可靠信，息。
整个第四段说到，准备参加临床试验的人们要尽可能多地了解有关临床试验的情况。